Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Dotinurad is a urate transporter 1 (URAT1) antagonist (IC50 = 0.0372 µM).1 It is selective for URAT1 over ATP-binding cassette subfamily G member 2 (ABCG2), organic anion transporter 1 (OAT1), and OAT3 (IC50s = 4.16, 4.08, and 1.32 µM, respectively). In vivo, dotinurad (30 mg/kg) decreases plasma levels of urate and increases urine levels of urate in Cebus monkeys. Formulations containing dotinurad have been used in the treatment of hyperuricemia and gout.
WARNING This product is not for human or veterinary use.
1. Pharmacological evaluation of dotinurad, a selective urate reabsorption inhibitor. J. Pharmacol. Exp. Ther. 371(1), 162-170 (2019).